Yi L P, Zhang W, Wu Z, Duan W J, Wang Y, Huang J, Ou X J, You H, Jia J D
Liver Reseach Center, Beijing Friendship Hospital, Capital Medical University, Clinical Research Center for Rare Liver Diseases, National Clinical Research Center for Digestive Diseases, Beijing 100050, China.
Zhonghua Gan Zang Bing Za Zhi. 2019 Mar 20;27(3):161-165. doi: 10.3760/cma.j.issn.1007-3418.2019.03.001.
Hepatolenticular degeneration (HLD) is an autosomal recessive inherited disorder of copper metabolism. The mutations in the ATP7B gene on chromosome 13 leads to the functional defect of ATP7B, which produces pathological deposits of copper in liver, brain, cornea and kidney, with diverse clinical manifestations in various forms of liver disease, nervous system disease and corneal disease (Kayser-Fleischer rings). Early diagnosis and proper treatment can improve the prognosis of hepatolenticular degeneration. Conversely, it may progress to end-stage liver disease or severe motor dysfunction, which seriously affects patient quality of life.
肝豆状核变性(HLD)是一种常染色体隐性遗传的铜代谢紊乱疾病。13号染色体上ATP7B基因的突变导致ATP7B功能缺陷,从而在肝脏、脑、角膜和肾脏中产生铜的病理性沉积,在各种形式的肝脏疾病、神经系统疾病和角膜疾病(凯-弗环)中表现出多样的临床表现。早期诊断和恰当治疗可改善肝豆状核变性的预后。相反,其可能进展为终末期肝病或严重运动功能障碍,严重影响患者生活质量。